GE HealthCare Technologies (GEHC) Stock: Buy, Sell, or Hold?
GEHC - GE HealthCare Technologies Inc. Common Stock
$63.93
-0.31 (-0.48%)
▼
5d:
-8.3%
30d:
-11.55%
90d:
-0.9%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 4, 2026 at $68.86 · last confirmed Sep 9, 2026
Strength: 7.3/10
Get Alerted When GEHC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: GEHC shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: GEHC shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$102.62
Based on 6.9% avg growth
INTRINSIC VALUE TODAY
$63.72
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 13.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GEHC is currently trading at $63.93, which is considered oversold relative to its 30-day fair value range of $68.20 to $74.06. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.8) compared to its historical average (13.6). Remarkably, the market is currently pricing in an annual earnings decline of 4.5% over the next few years. This pessimistic expectation contrasts with the company's recent 16.8% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, GEHC is in a uptrend. The price is currently testing key support at $63.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: GEHC scores 28/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $82.50 (+29.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GEHC is in a uptrend. The price is currently testing key support at $63.22. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: GEHC scores 28/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $82.50 (+29.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$68.20 -
$74.06
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding GEHC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (28/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.0% below Wall St target ($82.50)
- WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$68.20 -
$74.06
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$63.22
Resistance Level
$73.00
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.82
Wall Street Target
$82.50
(+29.0%)
Revenue Growth (YoY)
5.8%
Earnings Growth (YoY)
16.8%
Profit Margin
9.3%
Valuation Discount vs History
-4.5% cheaper
PE vs Historical
11.8 vs 13.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.5%
(market-implied from PE analysis)
1-Year Target
$61.05
(-5%)
2-Year Target
$58.31
(-9%)
3-Year Target
$55.68
(-13%)
3-Yr Target (if PE normalizes)
(PE: 12→14)
$64.09
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.2, Growth: 9.8%)
$144.44
(+126%)
Base:
(SPY PE: 11.8, Growth: 9.8%)
$84.62
(+32%)
Bear:
(PE: 10.0, Growth: 9.8%)
$71.93
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (15x PE), but valuation improves significantly next year (12x PE) as earnings recover.
Trailing PE: 15.01 | Current EPS (TTM): $4.28
Bull Case
$89.32
(+40%)
Analyst growth 26.4%, PE expands to 16.5
Base Case
$81.20
(+27%)
Market implied 26.4%, PE stable at 15.0
Bear Case
$43.68
(-32%)
Severe decline -20.0%, PE contracts to 12.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.8 to 13.6
Stabilization Target:
$73.58
(+15.1%)
PE Expansion Potential:
+15.1%
Share & Embed Analysis
Last updated: September 12, 2026 2:01 AM ET
Data refreshes hourly during market hours. Next update: 3:01 AM
Data refreshes hourly during market hours. Next update: 3:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GEHC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Terri A. Sewell
SELL
2026-03-25
Warren Davidson
SELL
2026-03-23
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 56 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 41 HOLD |
Advanced GEHC Option Strategies
Professional options setups generated by AI based on today's GEHC price and gamma walls.
